FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lorazepam Injection
Status: Currently in Shortage
»Date first posted: 05/03/2018
»Therapeutic Categories: Neurology

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 04/02/2026)

Company Contact Information:
800-423-4136

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)	Limited Availability	Limited Availability	Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 04/02/2026)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)	Available	Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Revised 03/12/2026)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)	Limited Availability	Lots are being manufactured to meet demand	Demand increase for the drug
Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)	Unavailable	Unavailable	Other
Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)	Unavailable	Unavailable	Other
Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)	Unavailable	Unavailable	Other
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)	Limited Availability	Lots are being manufactured to meet demand	Demand increase for the drug
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)	Unavailable	Unavailable	Other
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)	Unavailable	Unavailable	Other
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)	Unavailable	Unavailable	Other

Hospira, Inc., a Pfizer Company (Revised 04/10/2026)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)	Limited Availability	Limited Supply Available. Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay	Other